PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 67 filers reported holding PASSAGE BIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,445 | -12.7% | 110,099 | +24.9% | 0.00% | – |
| Q2 2023 | $82,974 | +34.6% | 88,148 | +36.9% | 0.00% | – |
| Q1 2023 | $61,655 | -59.4% | 64,378 | -41.4% | 0.00% | – |
| Q4 2022 | $151,681 | -51.5% | 109,914 | -56.0% | 0.00% | – |
| Q3 2022 | $313,000 | -65.5% | 250,079 | -35.0% | 0.00% | – |
| Q2 2022 | $908,000 | +13.4% | 384,567 | +48.9% | 0.00% | – |
| Q1 2022 | $801,000 | +67.9% | 258,290 | +243.9% | 0.00% | – |
| Q4 2021 | $477,000 | -35.1% | 75,115 | +1.8% | 0.00% | – |
| Q3 2021 | $735,000 | -28.8% | 73,808 | -5.4% | 0.00% | – |
| Q2 2021 | $1,033,000 | -91.3% | 78,029 | -88.5% | 0.00% | -100.0% |
| Q1 2021 | $11,811,000 | +4720.8% | 675,687 | +3524.0% | 0.00% | – |
| Q3 2020 | $245,000 | -60.9% | 18,645 | -18.7% | 0.00% | – |
| Q2 2020 | $627,000 | +213.5% | 22,943 | +80.2% | 0.00% | – |
| Q1 2020 | $200,000 | – | 12,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |